Summit Therapeutics (SMMT) Net Cash Flow (QoQ) (2017 - 2026)
Summit Therapeutics (SMMT) Net Cash Flow (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - |
| 2 | Nanobiotix | 1,911.11 Bn | 1,911.05 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 467.81 Bn | 463.02 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.92 Bn | 115.68 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn |
| 10 | Summit Therapeutics | 10.43 Bn | 9.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 363.49% |
| Mar 31, 2026 | -794.47% |
| Dec 31, 2025 | 77.63% |
| Sep 30, 2025 | -168.77% |
| Jun 30, 2025 | -19.07% |
| Mar 31, 2025 | 852.21% |
| Dec 31, 2024 | -82.83% |
| Sep 30, 2024 | 298.45% |
| Jun 30, 2024 | -236.15% |
| Mar 31, 2024 | -120.65% |
| Dec 31, 2023 | 360.88% |
| Sep 30, 2023 | 37.71% |
| Jun 30, 2023 | 94.96% |
| Mar 31, 2023 | -210.06% |
| Dec 31, 2022 | 690.32% |
| Sep 30, 2022 | 440.66% |
| Jun 30, 2022 | -434.94% |
| Mar 31, 2022 | 172.47% |
| Dec 31, 2021 | 64.88% |
| Sep 30, 2021 | -3,123.12% |